Cidara Therapeutics, Inc. (CDTX)

Cidara Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	54	72	54	85	88	127
Market Cap Growth	-26.40%	32.57%	-36.04%	-3.62%	-30.74%	94.55%
Enterprise Value	30	41	23	27	53	78
PE Ratio	-	-3.13	-1.61	-1.99	-1.17	-3.09
PS Ratio	1.17	1.12	0.84	1.71	7.28	6.07
PB Ratio	-4.68	-8.75	-3.75	3.93	8.20	3.35
P/FCF Ratio	-4.47	-3.13	-1.89	-3.35	-1.61	-4.44
P/OCF Ratio	-4.58	-3.20	-1.90	-3.36	-1.62	-4.45
EV/Sales Ratio	0.65	0.64	0.35	0.55	4.38	3.75
EV/EBITDA Ratio	-1.67	-1.93	-0.70	-0.65	-0.74	-1.91
EV/EBIT Ratio	-1.61	-1.82	-0.68	-0.65	-0.74	-1.90
EV/FCF Ratio	-3.16	-1.78	-0.79	-1.09	-0.97	-2.74
Debt / Equity Ratio	-0.26	-0.59	-0.08	0.23	0.74	0.31
Debt / EBITDA Ratio	-0.13	-0.23	-0.04	-0.12	-0.11	-0.29
Debt / FCF Ratio	-0.25	-0.21	-0.04	-0.20	-0.15	-0.41
Quick Ratio	0.55	0.77	0.93	1.99	1.40	2.00
Current Ratio	0.72	0.90	1.09	2.11	1.48	2.18
Asset Turnover	0.74	0.91	1.23	0.81	0.17	0.31
Interest Coverage	-	-	-	-199.32	-274.23	-
Return on Equity (ROE)	5747.20%	-218.00%	1604.00%	-445.90%	-221.20%	-101.20%
Return on Assets (ROA)	-58.10%	-32.70%	-64.20%	-69.50%	-106.40%	-61.60%
Return on Capital (ROIC)	290.50%	734.56%	253.29%	-158.65%	-384.69%	-84.19%
Earnings Yield	-67.01%	-31.94%	-62.00%	-50.14%	-85.20%	-32.39%
FCF Yield	-34.20%	-31.94%	-52.79%	-29.84%	-62.13%	-22.52%
Buyback Yield / Dilution	10.31%	-25.15%	-33.18%	-26.22%	-38.83%	-15.71%
Total Shareholder Return	10.31%	-25.15%	-33.18%	-26.22%	-38.83%	-15.71%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).